Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days
Clinical trial NCT04971109 · COMPLETED
Trial details
- NCT number
- NCT04971109
- Sponsor
- SIGA Technologies
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2023-05-12
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.